Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
Status:
Not yet recruiting
Trial end date:
2027-10-31
Target enrollment:
Participant gender:
Summary
We are conducting this study as it has the potential to contribute to a more complete
understanding of the independent and combined effects of cannabis use and HIV on the brain
and on inflammation. Such knowledge may inform future strategies for treating brain disease
and inflammation. Participants will be randomly assigned to one of two groups, both of which
will receive the same treatment in a different order over a period of about 6 weeks. The
visits include physical examinations, blood tests, and other procedures designed to monitor
subject safety and measure the effect of the study drug.